Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
- Conditions
- Interventions
- Biological: Bleomycin SulfateDrug: Doxorubicin HydrochlorideDrug: Procarbazine HydrochlorideDrug: Vinblastine SulfateDrug: DacarbazineDrug: CyclophosphamideDrug: Etoposide phosphateDrug: prednisoneDrug: Radiation TherapyRadiation: Fludeoxyglucose F-18Procedure: computed tomographyProcedure: Positron Emission Tomography
- First Posted Date
- 2010-05-28
- Last Posted Date
- 2021-06-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 164
- Registration Number
- NCT01132807
- Locations
- 🇺🇸
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States
🇺🇸UMASS Memorial Cancer Center - University Campus, Worcester, Massachusetts, United States
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant
- Conditions
- Interventions
- Biological: anti-thymocyte globulinBiological: donor lymphocytesBiological: filgrastimBiological: therapeutic allogeneic lymphocytesDrug: busulfanDrug: fludarabine phosphateDrug: methotrexateDrug: mycophenolate mofetilDrug: tacrolimusOther: reduced-intensity transplant conditioning procedureProcedure: allogeneic hematopoietic stem cell transplantationProcedure: peripheral blood stem cell transplantation
- First Posted Date
- 2010-05-06
- Last Posted Date
- 2017-03-24
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 6
- Registration Number
- NCT01118013
- Locations
- 🇺🇸
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸Florida Hospital Cancer Institute at Florida Hospital Orlando, Orlando, Florida, United States
Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma
- First Posted Date
- 2010-05-06
- Last Posted Date
- 2021-12-01
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 101
- Registration Number
- NCT01118026
- Locations
- 🇺🇸
Iredell Memorial Hospital, Statesville, North Carolina, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Duke University Medical Center, Durham, North Carolina, United States
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2010-04-16
- Last Posted Date
- 2017-06-27
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 28
- Registration Number
- NCT01105312
- Locations
- 🇺🇸
Sparrow Regional Cancer Center, Lansing, Michigan, United States
🇺🇸Medcenter One Hospital Cancer Care Center, Bismarck, North Dakota, United States
🇺🇸Geisinger Medical Group - Scenery Park, State College, Pennsylvania, United States
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2010-04-07
- Last Posted Date
- 2022-11-03
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 362
- Registration Number
- NCT01099449
- Locations
- 🇺🇸
Piedmont Hospital, Atlanta, Georgia, United States
🇺🇸Northside Hospital Cancer Center, Atlanta, Georgia, United States
🇺🇸Mason District Hospital, Havana, Illinois, United States
Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2010-03-24
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 48
- Registration Number
- NCT01091454
- Locations
- 🇺🇸
Illinois CancerCare - Havana, Havana, Illinois, United States
🇺🇸Mason District Hospital, Havana, Illinois, United States
🇺🇸Riverside Methodist Hospital Cancer Care, Columbus, Ohio, United States
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
- First Posted Date
- 2010-03-15
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 46
- Registration Number
- NCT01086605
- Locations
- 🇺🇸
Galesburg Clinic, PC, Galesburg, Illinois, United States
🇺🇸Graham Hospital, Canton, Illinois, United States
🇺🇸Illinois CancerCare - Canton, Canton, Illinois, United States
Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2010-03-12
- Last Posted Date
- 2021-08-18
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 72
- Registration Number
- NCT01085630
- Locations
- 🇺🇸
Essentia Health - Duluth Clinic, Duluth, Minnesota, United States
🇺🇸Summa Center for Cancer Care at Akron City Hospital, Akron, Ohio, United States
🇺🇸CCOP - Hematology-Oncology Associates of Central New York, East Syracuse, New York, United States
DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701
- First Posted Date
- 2010-01-27
- Last Posted Date
- 2017-06-27
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 78
- Registration Number
- NCT01057459
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2010-01-01
- Last Posted Date
- 2018-07-23
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 313
- Registration Number
- NCT01041781
- Locations
- 🇺🇸
Palo Alto Medical Foundation-Camino Division, Mountain View, California, United States
🇺🇸Toledo Clinic Cancers Centers - Maumee, Maumee, Ohio, United States
🇺🇸Alvin and Lois Lapidus Cancer Institute at Sinai Hospital, Baltimore, Maryland, United States